CYP19A1 and posterior cortical atrophy: In addition to these findings, we demonstrate a trend for the markers ERα in TS and aromatase in TE in adding prognostic value (4–12% reduced 10-year CFFS in low versus high expression subgroups) within each pathological PCa stage (Table 3).